Stryker Corporation vs Tempus AI — how do they compare? Stryker Corporation trades at $319.04 (market cap $122.35B), while Tempus AI trades at $49.09 (market cap $8.69B). The key difference: Stryker Corporation is far larger — about 14.1× Tempus AI's market cap, and Stryker Corporation pays a 1% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| SYK | TEM | |
|---|---|---|
Market Cap | $122.35B | $8.69B |
Sector | Technology | Broad Market / Factor |
52-Week High | $403.53 | $103.25 |
52-Week Low | $282.58 | $42.37 |
Enterprise Value | $134.10B | $9.37B |
Dividend Yield | 1% | — |
Trailing returns across standard periods
Latest headlines on both assets
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →